News · 18 November 2026

New lung cancer pill cuts the risk of death by 44% in a trial

18 November 2026 · Madrid · Health · Science · Uplifting

New lung cancer pill cuts the risk of death by 44% in a trial
Picture: Medscape · Medscape lead image · unknown

A new lung cancer pill, divarasib, beat two approved drugs in a trial. It cut the risk of death by 44% for patients with a gene change called KRAS G12C. Patients lived a median of 17.7 months, against 12 on older drugs. Researcher Ferdinandos Skoulidis called it "a new standard of care."

Where this came from. 2 outlets reported this. We read them, then wrote the sixty words above.

Also on 18 November 2026